COVID-19 vaccines
Showing 1 - 25 of >10,000
COVID-19, Influenza, Vaccine Reaction Trial in Seoul, Incheon (Omicron-containing COVID-19 vaccine, influenza vaccine)
Recruiting
- COVID-19
- +3 more
- Omicron-containing COVID-19 vaccine
- influenza vaccine
-
Seoul, Guro-gu, Korea, Republic of
- +1 more
Oct 17, 2023
Assessment of Safety and Satisfaction Toward COVID-19 Vaccines.
Completed
- COVID-19 Vaccine Adverse Reaction
- COVID-19 Vaccine questionnaire
-
Damanhūr, Elbehairah, EgyptRehab Hussein Werida
May 10, 2023
Expectations About the COVID-19 Vaccines
Active, not recruiting
- Vaccine Adverse Reaction
- COVID-19 vaccine
-
Aarhus, DenmarkAarhus University
Nov 10, 2022
COVID-19 Vaccines and the Menstrual Cycle
Completed
- Menstrual Irregularity
- Naser Al-Husban
-
Amman, JordanJordan University Hospital
Jan 17, 2023
Immune Response, Safety Trial in Incheon (bivalent BNT162b2 mRNA original/omicron BA.4-5 vaccine, quadrivalent influenza
Active, not recruiting
- Immune Response
- Safety
- bivalent BNT162b2 mRNA original/omicron BA.4-5 vaccine
- quadrivalent influenza vaccine
-
Incheon, Seo-gu, Korea, Republic ofInternational St. Mary's hospital
Jul 28, 2023
COVID-19 Trial in Johannesburg (AAHI-SC2 Vaccine, AAHI-SC3 Vaccine, EUA or approved vaccine)
Recruiting
- COVID-19
- AAHI-SC2 Vaccine
- +2 more
-
Johannesburg, South AfricaWits Vida
Jan 4, 2023
Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients
Not yet recruiting
- Covid-19 Pandemics
- Tuberculosis
- Pfizer-BioNTech COVID-19 vaccine
- +2 more
-
Mae Sot, Tak, ThailandShoklo Malaria Research Unit (SMRU)
Oct 21, 2022
SARS-CoV-2 Infection Among Healthcare Workers
Recruiting
- COVID-19
- inactivated COVID-19 vaccines; orally aerosolized Ad5-nCoV
-
Nanjing, Jiangsu, ChinaThe Affiliated Nanjing Drum Tower Hospital of Nanjing University
Jan 10, 2023
SARS-CoV-2 Specific CD8 T-Cell Responses to COVID-19 Vaccines in
Recruiting
- COVID-19
-
Baltimore, Maryland
- +1 more
Feb 2, 2023
Inactivated COVID-19 Vaccine in Thousands of Autoimmune Diseases
Recruiting
- COVID-19 Vaccines
- Autoimmune Diseases
- the inactivated COVID-19 vaccines
-
Hangzhou, Zhejiang, ChinaThe Affiliated Hospital of Zhejiang Chinese Medicine University
Apr 25, 2023
COVID-19 Vaccines Using Information From California State
Not yet recruiting
- SARS-CoV-2
- +2 more
- Pfizer-BioNTech COVID-19 bivalent mRNA vaccine
- (no location specified)
May 23, 2023
Thrombotic Thrombocytopenia Syndrome and Exposure To COVID-19
Recruiting
- Covid-19
- Pre-COVID-19
- +2 more
-
Oxford, United KingdomResearch site
Jul 29, 2022
COVID-19, Vaccine-Preventable Diseases, SARS CoV 2 Infection Trial (Novavax COVID-19 vaccine (2023-2024 formula XBB containing),
Not yet recruiting
- COVID-19
- +4 more
- Novavax COVID-19 vaccine (2023-2024 formula XBB containing)
- Pfizer COVID-19 mRNA vaccine (2023-2024 formula XBB containing)
- (no location specified)
Sep 29, 2023
COVID-19 Trial in Wuhan (Prototype and Omicron BA.4/5 Bivalent Recombinant COVID-19 Vaccine(Adenovirus Type 5 Vector) For
Recruiting
- COVID-19
- Prototype and Omicron BA.4/5 Bivalent Recombinant COVID-19 Vaccine(Adenovirus Type 5 Vector) For Inhalation
- +2 more
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Jun 1, 2023
COVID-19 Trial (NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine, Prototype/XBB.1.5 Bivalent Vaccine (5 µg))
Not yet recruiting
- COVID-19
- NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine
- Prototype/XBB.1.5 Bivalent Vaccine (5 µg)
- (no location specified)
Aug 4, 2023
COVID-19 Vaccines and the Development of New LUTS
Completed
- COVID-19 Vaccine Adverse Reaction
- Lower Urinary Tract Symptoms
-
Zarqa, JordanThe Hashemite University
Oct 14, 2022
Chinese COVID-19 Vaccines in Latin America and the Caribbean
Not yet recruiting
- COVID-19
- (no location specified)
Jul 26, 2022
GENE SEQUENCING AS A STRATEGY FOR IDENTIFYING GENETIC FACTORS
Recruiting
- Covid-19 Vaccination Serious Adverse Events
-
Rio De Janeiro, BrazilUnidade de Ensaios Clínicos para Imunobiológicos (UECI)
Nov 23, 2022
Assess Immunogenicity of Nationally Authorized Homologous
Not yet recruiting
- COVID-19
- Immune Responses
- (no location specified)
Jan 31, 2023
Liver Disease Chronic Trial in Beijing (COVID-19 Vaccines)
Recruiting
- Liver Disease Chronic
- COVID-19 Vaccines
-
Beijing, Beijing, ChinaThe Fifth Medical Center of PLA General Hospital
Apr 17, 2022
Vaccine Confidence and Uptake of Potential COVID-19 Vaccines
Recruiting
- Coronavirus
- Survey research
-
Greenville, North CarolinaCarol Belk Building
Sep 8, 2022
Vaccine Adverse Reaction, Side-Effect Trial (Mulberry juice)
Not yet recruiting
- Vaccine Adverse Reaction
- Side-Effect
- Mulberry juice
- (no location specified)
May 20, 2022
COVID-19 Vaccines in Immunocompromised and Healthy Individuals
Recruiting
- Covid19
- Immunosuppression
- Blood sample
- Saliva sample
-
Graz, AustriaMedical University of Graz
May 9, 2022
COVID-19 Trial in Bizerte, Ariana, Tunis (CoronaVac/CoronaVac, CoronaVac/BNT162b2)
Completed
- COVID-19
- CoronaVac/CoronaVac
- CoronaVac/BNT162b2
-
Bizerte, Mateur, Tunisia
- +4 more
Jan 4, 2023
COVID-19 Vaccines Trial in Panama, Philippines, United States (UB-612, BNT162b2 vaccine, ChAdOx1-S vaccine)
Active, not recruiting
- COVID-19 Vaccines
- UB-612
- +3 more
-
Brownsville, Texas
- +6 more
Oct 11, 2022